i-SEP
Created in 2015
Up & running (A)
Existing signals show a regular activitySocial networks
2,107Activities
Technologies
Entity types
Location
21 Rue La Noue Bras de Fer, 44200 Nantes, France
Nantes
France
Employees
Scale: 11-50
Estimated: 39
SIREN
814086534Engaged catalyst
11
0 0Added in Motherbase
1 year, 4 months ago
Value proposition
[Automatic translation follows] - We Believe in Safer Blood -
Founded in 2015 in Nantes, I-SEP is a medtech specializing in peroperative self-transfusion and patient blood management. At I-SEP, we have developed, patented and now markets an innovative technology for recovery and separation of blood components.
In collaboration with our clinicians, we are developing unique blood management solutions for patients to improve the benefits for patients and stakeholders.
We are working closely with specialized clinicians in order to improve the benefits for patients, simplify the workflow of doctors and help reduce health care costs.
Our innovation provides significant added value compared to the solutions currently available, especially in terms of blood quality.
I-SEP was co-founded by three partners:
Dr Francis Gadrat, anesthesiologist, Bertrand Chastenet, former business manager and consultant in the pharmaceutical industry, Foreign trade advisor, and Sylvain Picot, founder of Biom’up. I-SEP is accompanied by Atlanpole and member of the Atlanpole Biotherapies competitiveness cluster.
-----
Founded in 2015 in Nantes (Upper British, France), i-sep is a medtech specialized in intraoperative self-transfusion and patient blood management. At I-SEP, we have developed, patented and now innovative technology for the recovery and separation of Blood Components.
Together with our clinicians, we develop unique patient Blood Management Solutions for improved patient & amp; Stakeholder Benefits.
We work closely with specialized clinicians with the love of improving patient benefits, simplifying physicians ’workflow and helping reduce healthcare cost.
OUR innovation BRINGS NEW ADDED VALUE COMPARED TO CURRENTLY Available Solutions, Particularly in Terms of Blood Quality.
Patient Blood Management, Perioperative Cell Recovery, Anesthesiology, Medtech, Self -Transfusion, and IocsOriginal language
- We believe in safer blood -
Fondée en 2015 à Nantes, i-SEP est une medtech spécialisée dans l'autotransfusion peropératoire et la gestion du sang des patients. Chez i-SEP, nous avons développé, breveté et commercialisons désormais une technologie innovante de récupération et de séparation des composants sanguins.
En collaboration avec nos cliniciens, nous développons des solutions uniques de gestion du sang des patients pour améliorer les avantages pour les patients et les parties prenantes.
Nous travaillons en étroite collaboration avec des cliniciens spécialisés dans le but d’améliorer les avantages pour les patients, de simplifier le flux de travail des médecins et de contribuer à réduire les coûts des soins de santé.
Notre innovation apporte une valeur ajoutée significative par rapport aux solutions actuellement disponibles, notamment en termes de qualité du sang.
i-SEP a été co-fondée par trois associés :
Dr Francis Gadrat, médecin anesthésiste, Bertrand Chastenet, ancien chef d’entreprise et consultant dans l'industrie pharmaceutique, conseiller du commerce extérieur de la France, et Sylvain Picot, fondateur de Biom’Up. i-SEP est accompagnée par Atlanpole et membre du pôle de compétitivité Atlanpole Biothérapies.
------
Founded in 2015 in Nantes (Upper Britany, France), i-SEP is a medtech specialized in intraoperative autotransfusion and Patient Blood Management. At i-SEP, we have developed, patented and now markets an innovative technology for the recovery and separation of blood components.
Together with our clinicians, we develop unique Patient Blood Management solutions for improved patient & stakeholder benefits.
We work closely with specialized clinicians with the aim of improving patient benefits, simplifying physicians’ workflow and helping reduce healthcare cost.
Our innovation brings significant added value compared to currently available solutions, particularly in terms of blood quality.
Patient Blood Management, PeriOperative Cell Recovery, Anesthesiology, MedTech, Autotransfusion, and IOCS
i-SEP - the alternative to allogeneic blood transfusions
i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .i-SEP has developed and patented an innovative technology for the separation of blood components.
https://www.i-sep.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 INRAE Research, Research Services | INRAE Research, Research Services | Other 2 Apr 2025 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 27 Oct 2024 | | |
 Samoa Architecture and Planning | Samoa Architecture and Planning | Other 12 Jul 2024 | | |
 Nantes Métropole Government Administration, French metropolis | Nantes Métropole Government Administration, French metropolis | Other 12 Jul 2024 | | |
 Région Pays de la Loire National and local authorities, Government Administration | Région Pays de la Loire National and local authorities, Government Administration | Other 12 Jul 2024 | | |
 Chambre de Commerce et d'Industrie de Nantes St-Nazaire Chamber of commerce, Government Administration | Chambre de Commerce et d'Industrie de Nantes St-Nazaire Chamber of commerce, Government Administration | Other 12 Jul 2024 | | |
 Atlanpole Business Consulting and Services | Atlanpole Business Consulting and Services | Other 27 Oct 2024 | | |
 NEFTYS Finance, Financial Services | NEFTYS Finance, Financial Services | Other 30 Nov 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 17 Dec 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 27 Oct 2024 | | |